Joanne Kotz has been named CEO of Jnana Therapeutics. Kotz, a co-founder of Jnana, had been president of the Boston-based company since last December, when it raised $50 million in Series A financing. Jnana is researching drugs that target solute carrier transporters, which are proteins that move substances across cellular membranes.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
